Adjuvant Epirubicin With or Without Ifosfamide for Adult Soft-Tissue Sarcoma

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Clinical Oncology

• Publication date

  2002-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000421-200210000-00009PMID 12393986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transposon Silencing Keeps Jumping Genes in Their Place

  2006influential reference
• Adjuvant therapy of sarcomas of soft tissue.

  1997cited by this paper
• Cancer statistics, 1995

  1995cited by this paper
• Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

  1995cited by this paper
• Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.

  1995cited by this paper
• Prognostic Factors Predictive of Survival and Local Recurrence for Extremity Soft Tissue Sarcoma

  1994cited by this paper
• Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

  1994cited by this paper
• Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

  1993cited by this paper
• Marginal surgery and postoperative radiotherapy in soft tissue sarcomas. The Scandinavian Sarcoma Group experience.

  1993cited by this paper
• Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult advanced soft tissue sarcomas.

  1992cited by this paper
• The clinical management of soft tissue sarcomas.

  1992cited by this paper
• Soft Tissue Sarcoma Integration of Brachytherapy, Resection, and External Irradiation

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.

  1989cited by this paper
• Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity.

  1988cited by this paper
• Treatment of the patient with stage M0 soft tissue sarcoma.

  1988cited by this paper
• A Randomized Prospective Trial Using Postoperative Adjuvant Chemotherapy (Adriamycin) in High‐Grade Extremity Soft‐Tissue Sarcoma

  1988cited by this paper
• Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma

  1985cited by this paper
• Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas.

  1984cited by this paper
• Manual of Soft Tissue Tumor Surgery

  1984cited by this paper
• The grading of soft tissue sarcomas results of a clinicohistopathologic correlation in a series of 163 cases

  1984cited by this paper
• Musculoskeletal tumor surgery

  1983cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Systemic Treatment in Soft Tissue Sarcomas: Are We Making a Difference?

  2025cites this paper
• Wound Healing Complications after Neoadjuvant Radiotherapy Combined with Targeted Therapies in Soft Tissue Sarcoma Patients.

  2025cites this paper
• Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and survival outcomes – A systematic review and meta‐analysis of randomized controlled trials

  2025cites this paper
• Neoadjuvant or Adjuvant Chemotherapy in Soft-Tissue Sarcoma?

  2025cites this paper
• Organoid models derived from patients with malignant phyllodes tumor of the breast

  2023cites this paper
• Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?

  2023cites this paper
• Prediction tools for the personalized management of soft-tissue sarcomas of the extremity

  2022cites this paper
• The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC.

  2022cites this paper
• Soft Tissue Sarcomas with Special Reference to Molecular Aberration, Chemotherapy, and Recent Advances: A Review Article

  2022cites this paper
• Retroperitoneal Sarcomas: a Current Review on Management

  2022influential citation
• Soft Tissue Sarcoma, Version 2.2022

  2022cites this paper
• Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward

  2022cites this paper
• Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

  2022cites this paper
• Comparison of Different Systemic Therapeutic Regimes in Resectable Soft-Tissue Sarcoma—Results of a Network Meta-Analysis

  2021cites this paper
• Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis

  2021cites this paper
• The evolution of adjuvant/neoadjuvant trials for resectable localized sarcoma

  2021cites this paper
• Pleomorphic liposarcoma

  2020cites this paper
• Sarcomas of Soft Tissue

  2020cites this paper
• Radiotherapie und Radio-/ Chemotherapie von Weichteilsarkomen

  2020influential citation
• Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine

  2020cites this paper
• Management of A Paraglottic Synovialosarcoma: About A Case

  2020cites this paper
• Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study

  2020cites this paper
• Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta‐analysis of chemotherapy and survival outcomes in resectable STS

  2019influential citation
• Management of localized extremity and retroperitoneal soft tissue sarcoma.

  2019cites this paper
• Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas

  2018cites this paper
• The Future of Radiation Oncology in Soft Tissue Sarcoma

  2018cites this paper
• Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).

  2018cites this paper
• Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas

  2018cites this paper
• Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma.

  2018cites this paper
• Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy

  2018cites this paper
• Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial

  2018cites this paper
• Biological indicators of chemoresistance: an ex vivo analysis of γH2AX and p53 expression in feline injection-site sarcomas

  2018cites this paper
• Neoadjuvant Chemotherapy Plus Regional Hyperthermia and Long-termOutcomes Among PatientsWith Localized High-Risk Soft Tissue Sarcoma The EORTC 62961-ESHO 95 Randomized Clinical Trial

  2017cites this paper
• Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.

  2017cites this paper
• Systemic Treatments in Soft Tissue Sarcomas.

  2017cites this paper
• Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience

  2017cites this paper
• Evaluation of Quality of Life at Progression in Patients with Soft Tissue Sarcoma

  2017cites this paper
• Treatment of intimal sarcoma of peripheral veins

  2017cites this paper
• Multimodal Treatment for Soft Tissue Sarcoma of the Extremity OPEN ACCESS

  2017cites this paper
• (Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair.

  2017cites this paper
• Rare neoplasm of genito-urinary tract. Genito-urinary sarcomas: chemotherapy

  2017cites this paper
• SOFT TISSUE SARCOMAS OF THE LIMBS: MULTIDISCIPLINARY TREATMENT

  2017cites this paper
• Colonoscopy colorectal cancer screening: Cost-effectiveness in Thailand

  2016cites this paper
• Adjuvant chemotherapy in soft tissue sarcomas…Conflicts, consensus, and controversies

  2016cites this paper
• NCCN Soft Tissue Sarcoma , Version 2 . 2016 Clinical Practice Guidelines in Oncology

  2016cites this paper
• Chemotherapy: Does Neoadjuvant or Adjuvant Therapy Improve Outcomes?

  2016cites this paper
• Multimodality Management of Soft Tissue Tumors in the Extremity.

  2016cites this paper
• Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

  2016cites this paper
• Retroperitoneal Liposarcoma: A Comprehensive Review

  2015cites this paper
• A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.

  2015cites this paper
• Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.

  2015cites this paper
• Soft tissue limb and trunk sarcomas: diagnosis, treatment and follow-up.

  2014cites this paper
• Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial

  2014cites this paper
• Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.

  2014cites this paper
• The role of inflammation in sarcoma.

  2014cites this paper
• Phase I Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients with Locally Advanced Soft Tissue Sarcoma of the Extremity

  2014cites this paper
• Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas.

  2013influential citation
• Issues in the management of high-risk localized sarcomas.

  2013cites this paper
• Chemotherapy Use in Elderly Patients with Soft Tissue Sarcoma: A Population-based Study

  2013cites this paper
• Mode of action of trabectedin in human mixoid liposarcoma growing in immunodeficient mice : evidence that the drug acts by displacing FUS-CHOP chimeric protein from its target promoters

  2012cites this paper
• Dedifferentiated liposarcoma arising from the mesocolon ascendens: report of a case.

  2012cites this paper
• Is adjuvant chemotherapy useful for soft-tissue sarcomas?

  2012cites this paper
• Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy

  2012cites this paper
• Adjuvant chemotherapy for soft tissue sarcomas.

  2012cites this paper
• Prognostic Value of Tc-99m-MIBI Performed During Middle Course of Preoperative Chemotherapy in Patients With Malignant Bone and Soft-Tissue Tumors

  2012cites this paper
• Peri-operative Therapies for Localized Retroperitoneal Soft Tissue Sarcoma

  2012cites this paper
• Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

  2012cites this paper
• Toxicity associated with epirubicin treatments in a large case series of dogs.

  2012cites this paper
• Uncommon Cancers of the Prostate

  2012cites this paper
• Management of retroperitoneal sarcomas: main prognostic factors for local recurrence and survival.

  2012cites this paper
• Choosing the right option for renal-cell carcinoma

  2012cites this paper
• Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma

  2011cites this paper
• Systemic Therapy in Soft Tissue Sarcomas: Past, Present and Future

  2011cites this paper
• Treating soft tissue sarcomas with adjuvant chemotherapy

  2011cites this paper
• Appraising the current role of chemotherapy for the treatment of sarcoma.

  2011cites this paper
• Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.

  2011cites this paper
• Extremity Soft Tissue Sarcoma in Adults

  2011cites this paper
• Primary chest wall tumors.

  2010cites this paper
• [Adjuvant chemotherapy of adults soft tissue sarcomas].

  2010cites this paper
• Rare Malignancies of the Skin

  2010cites this paper
• Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial

  2010cites this paper
• Role of chemotherapy in the management of soft tissue sarcomas

  2010cites this paper
• Randomized clinical trials in soft tissue sarcoma.

  2010cites this paper
• Chemotherapy for gynecologic cancers.

  2009cites this paper
• Current nonsurgical treatment options and concepts for soft tissue sarcoma in adults

  2009cites this paper
• The Value of Surgery for Retroperitoneal Sarcoma

  2009cites this paper
• Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?

  2009cites this paper
• A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma

  2008cites this paper
• Centralised treatment of soft tissue sarcomas in adults

  2008cites this paper
• Diagnosis and management of lipomatous tumors

  2008cites this paper
• Treatment of soft tissue sarcoma: a European approach.

  2008cites this paper
• Clinical and molecular studies of liposarcoma

  2007cites this paper
• Standards and novel therapeutic options in the treatment of patients with soft tissue sarcoma.

  2007cites this paper
• Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome.

  2007cites this paper
• Controversies in Surgical Oncology: Routine Anthracycline-based Adjuvant Chemotherapy for Stage III Extremity Soft Tissue Sarcoma

  2007cites this paper
• Evidence-based recommendations for local therapy for soft tissue sarcomas.

  2007cites this paper
• Treatment of localized soft-tissue sarcoma: lessons learned.

  2007cites this paper
• To dream the possible dream

  2006cites this paper
• Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

  2006cites this paper
• Adjuvant therapy for extremity sarcomas

  2006cites this paper